Subretinal hemorrhage due to ruptured retinal arterial macroaneurysm: Case report
Revista Ciencia y Salud / eISSN: 2215-4949 / https://revistacienciaysalud.ac.cr/ojs

Vol. 8 No. 2 (2024)Artículos

Vol. 8 No. 2 (2024)

Subretinal hemorrhage due to ruptured retinal arterial macroaneurysm: Case report

Artículos

Supplementary Files

PDF (Español (España))

Keywords

Retinal Arterial Macroaneurysm
Cataract
Crystalline Lens
Retinal Hemorrhage
Bevacizumab

How to Cite

Aray Coellar, I., Cervantes Anaya, L. A., Ortega Zapata, B. M., Muñoz Jiménez, T. N., & Ginarte Durán, Y. (2024). Subretinal hemorrhage due to ruptured retinal arterial macroaneurysm: Case report. Revista Ciencia Y Salud, 8(2), 47–52. https://doi.org/10.34192/cienciaysalud.v8i2.732

Abstract

Retinal arterial macroaneurysm is a rare condition in the population, and it is generally observed in elderly people with metabolic comorbidities such as type II diabetes mellitus and arterial hypertension, which predispose to retinal vessel sclerosis. In view of the above, we present the case of an 87-year-old female patient who came for ophthalmologic consultation due to vision loss. Physical examination revealed opacification of the crystalline lens and simple myopic astigmatism in both eyes, in addition, complementary tests showed corneal thinning, bilateral exudates and subretinal hemorrhage in the right eye. Therefore, he was diagnosed with retinal arterial macroaneurysm and cataract on the right side. As a treatment it was decided to administer anti-vascular endothelial growth factor (Bevacizumab) for five months in order to avoid macular deformation, and then a retinal laser surgery was performed.

https://doi.org/10.34192/cienciaysalud.v8i2.732
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2024 Irma Aray Coellar, Luis Alberto Cervantes Anaya, Bryam Mateo Ortega Zapata, Tamara Nicole Muñoz Jiménez, Yadira Ginarte Durán

Downloads

Download data is not yet available.